|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.450 CNY | -3.67% |
|
-4.74% | -59.51% |
| Aug. 14 | Novogene Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024 | CI |
| Jul. 02 | Tranche Update on Novogene Co., Ltd.'s Equity Buyback Plan announced on February 6, 2024. | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions on site
| Capitalization | 3.84B 542M | P/E ratio 2024 * |
19.4x | P/E ratio 2025 * | 16x |
|---|---|---|---|---|---|
| Enterprise value | 9.71B 1.37B | EV / Sales 2024 * |
1.7x | EV / Sales 2025 * | 1.47x |
| Free-Float |
23.54% | Yield 2024 * |
1.06% | Yield 2025 * | 1.59% |
More valuation ratios
* Estimated data
More news
| 1 day | -3.67% | ||
| 1 week | -4.74% | ||
| Current month | -8.78% | ||
| 1 month | -10.26% | ||
| 3 months | -21.77% | ||
| 6 months | -37.75% | ||
| Current year | -59.51% |
1 week
9.41
10.15
1 month
9.4110.68
Current year
9.4123.56
1 year
9.4126.60
3 years
9.4156.50
5 years
9.4169.82
10 years
9.4169.82
| Director | Title | Age | Since |
|---|---|---|---|
Rui Qiang Li
CEO | Chief Executive Officer | 44 | 11-03-14 |
Shi Shan Shi
DFI | Director of Finance/CFO | 42 | 14-03-31 |
Qi Feng Wang
BRD | Director/Board Member | 46 | 12-01-31 |
| Manager | Title | Age | Since |
|---|---|---|---|
Rui Qiang Li
CEO | Chief Executive Officer | 44 | 11-03-14 |
Qi Feng Wang
BRD | Director/Board Member | 46 | 12-01-31 |
Quan Gan
BRD | Director/Board Member | 48 | 22-06-14 |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| -3.67% | -4.74% | -57.91% | -77.97% | 542M | ||
| +0.24% | +1.53% | -12.06% | -35.28% | 8.8B | ||
| -2.61% | +8.50% | +131.57% | +138.08% | 4.88B | ||
| -0.21% | -1.27% | +41.26% | -18.50% | 3.32B | ||
| -0.18% | -.--% | +25.47% | -45.19% | 2.7B | ||
| -0.43% | +7.86% | +21.32% | -65.53% | 2.09B | ||
| -1.39% | -0.04% | -53.86% | -70.16% | 1.81B | ||
| +4.01% | -0.24% | +13.40% | -28.49% | 1.64B | ||
| +0.06% | +1.79% | +47.45% | -31.41% | 1.33B | ||
| -0.57% | -0.70% | +88.91% | +41.79% | 1.12B | ||
| Average | -0.47% | +1.18% | +24.55% | -19.27% | 2.82B | |
| Weighted average by Cap. | -0.39% | +2.10% | +29.84% | -5.94% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 2.26B 319M | 2.62B 370M |
| Net income | 204M 28.77M | 245M 34.54M |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
2,144
Calendar
2024-10-21
- Q3 2024 Earnings Release (Projected)
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-09-13 | 9.450 ¥ | -3.67% | 2,505,067 |
| 24-09-12 | 9.810 ¥ | -1.21% | 1,790,689 |
| 24-09-11 | 9.930 ¥ | +1.02% | 1,517,038 |
| 24-09-10 | 9.830 ¥ | -0.91% | 1,983,443 |
End-of-day quote Shanghai S.E., September 12, 2024
More quotes
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
9.450CNY
Average target price
13.39CNY
Spread / Average Target
+41.73%
Annual profits - Rate of surprise
- Stock Market
- Equities
- 688315 Stock